of T cells. Inhibitory action of IL-35 is because of arresting G1 phase of mitosis. 4 The IL-35 has a potential to activate nTreg cells especially at high inflammation sites. 5 Nakijima et al 6 have stated that patients with chronic periodontitis exhibited increased frequency of T lymphocytes and CD4 CD25 T cells in the inflammatory infiltrate of gingival tissues and also exhibited the phenotypic markers of Tregs, such as Foxp3. The search for potential markers associated with the severity, as well as the susceptibility of periodontal disease, has recently been receiving considerable attention. Few studies have been performed to evaluate the exact role of IL-35 in the etiology of periodontal disease. As of now only one study has compared the levels of IL-35 in plasma, saliva, and gingival crevicular fluid (GCF) in periodontal health and disease. 7 In our previous study,
we have compared the levels of IL-35 in periodontally healthy subjects and patients with chronic periodontits. 8 In the present study, the basic aim was to evaluate and compare IL-35 levels in patients with chronic gingivitis and chronic periodontitis.
MATERIALS AND METHODS

Study Design
A total of 30 systemically healthy individuals who are nonsmokers were selected for the present study.
Study Population
A total of 30 patients who reported to the outpatient department of Sharad Pawar Dental College and
INTRODUCTION
Chronic periodontitis is an inflammatory disease playing a role in the breakdown of alveolar bone, periodontal 
Gingival Crevicular Fluid Sampling
Gingival crevicular fluid samples were taken from two sites with papillary bleeding index (PBI) >2, PPD >3, and positive BOP in the chronic gingivitis group; from two sites (deepest pocket PD >5) with PBI >2 and positive BOP according to the baseline clinical measurements in the chronic periodontitis group. Maxillary sites were chosen to prevent saliva contamination. Gingival crevicular fluid samples were collected using calibrated capillary tube. Sampling areas were isolated properly. The GCF samples from sites of each individual were placed into one polypropylene tube and pooled before freezing at 70°C. Standard curve was taken as a reference to convert reading to actual volume. All GCF samples were stored at 80°C until laboratory analyses.
Clinical Measurements
The clinical evaluation of the patients was determined by PBI by Muhlemann, 9 modified plaque index by Turskey et al, 10 BOP, PPD, and CAL.
Measurement of IL-35 in GCF
The IL-35 levels were measured using an enzyme-linked immunosorbent assay (ELISA) kit. Initially, GCF samples were diluted by 300 mL phosphate-buffered saline (PBS). After adding 100 µL of each, dilution plate was incubated for 2 hours at 37°C. Next, 100 mL each of detection reagent A and reagent B was added and incubated for 1 hour and 30 minutes at 37°C respectively, along with 90 mL substrate solution, and the plate was incubated for 15 to 25 minutes at 37°C. Plate was read in ELISA reader. The diluted absorbance values of IL-35 (pg/µL) in GCF were multiplied by the dilution agent volume (300 mL PBS). The IL-35 concentrations in a unit volume (pg/µL) were then determined by multiplying the GCF IL-35 diluted absorbance values by 300 mL (to account for the dilution) and dividing by the GCF volume (µL).
Statistical Analysis
For all clinical parameters and IL-35 levels, mean and standard deviation were calculated. The following methods of statistical analysis have been used in this study: (1) To test the difference between the groups ANOVA (one-way analysis of variance) was used. F value is calculated and if F value is significant then it means that differences between the groups are significant. To find out which of the two groups mean is significantly different post hoc, Scheffe's test is used. In case F value is not significant, it indicates that there is no significant difference between the groups and stops the analysis at this stage and does not use least significant difference test. The formula used was:
F = MS between groups MS within groups
where MS = Mean Sum of Square (2) Pearson's correlation coefficient test is widely used in the sciences as a measure of the strength of linear dependence between two variables; p-value less than 0.05 was taken as significant in all the above tests. Statistical Package for the Social Sciences was used for the analysis of data. In all the above tests, p-value less than 0.05 was taken to be statistically significant.
RESULTS
Clinical parameters in the study are shown in Table 1 . Chronic periodontitis group showed significantly higher parameters statistically as compared with chronic gingivitis group (p < 0.001). Higher volume of GCF was obtained in chronic periodontitis group as compared with chronic gingivitis group. Gingival crevicular fluid levels of IL-35 are shown in Table 2 . The GCF concentration of IL-35 
DISCUSSION
The IL-35 is an anti-inflammatory cytokine and is a member of IL-12 superfamily. It arrests mitosis in G1 phase and inhibits proliferation of T cells; IL-35 also induces the development of iTr35 cells, a subset of Treg cells. 4 There The gingival tissue expression of EBI3 and IL-12A was significantly higher in the CP group than the healthy group. The findings of the present study are consistent with these results. Gingival crevicular fluid was used in this study because GCF has been the focus of most research in recent years. Gingival crevicular fluid is an exudate that flows into oral cavity from periodontal pockets. As a result of gingival inflammation, GCF is formed when fluid leaks from dilated blood vessels within the gingival connective tissue. As this fluid flows through the inflamed connective tissue, it picks up enzymes and other mediators involved in immune response. In this regard, it is an "inflammatory soup" containing subgingival bacteria and host cells. So, it offers a great potential as a source of factors that may be associated with disease activity. Koseglu evaluated the levels of IL-35 in plasma, saliva, and GCF in periodontally healthy individuals, gingivitis patients, and chronic periodontitis patients. In this study, mean GCF IL-35 level in healthy individuals was 63.19 pg/µL, 33.02 pg/µL in gingivitis patients, and 20.57 pg/µL in chronic periodontitis patients. The results in our study are comparable to the study by Koseglu. 7 In this study, the mean GCF However, the results might alter due to changes in the concentration of other anti-inflammatory cytokines, which cannot be denied. This is one of the important limitations of this study.
